Population Pharmacokinetics of Enrofloxacin in Ctenopharyngodon idella Based on the Sparse Sampling Method and a Nonlinear Mixed Effect Model Following Intravenous and Oral Administration

被引:1
作者
Xu, Ning [1 ,2 ]
Zhang, Huan [1 ,3 ]
Zhou, Shun [1 ,2 ]
Liu, Yongtao [1 ,2 ]
Yang, Qiuhong [1 ,2 ]
Dong, Jing [1 ,2 ]
Ding, Yongzhen [4 ]
Ai, Xiaohui [1 ,2 ]
机构
[1] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Wuhan, Peoples R China
[2] Hu Bei Prov Engn & Technol Res Ctr Aquat Prod Qual, Wuhan, Peoples R China
[3] Wuhan Polytech Univ, Coll Food Sci & Engn, Wuhan, Peoples R China
[4] Minist Agr & Rural Affairs, Agroenvironm Protect Inst, Tianjin, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
bioavailability; enrofloxacin; grass carp; population pharmacokinetics;
D O I
10.1111/jvp.13497
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to implement population pharmacokinetic (PPK) of enrofloxacin (EF) in grass carp (Ctenopharyngodon idella) after a single oral administration and a single intravenous administration based on a nonlinear mixed effect model. The plasma samples collected by the sparse sampling method were detected by high-performance liquid chromatography with a fluorescent detector. The initial pharmacokinetic (PK) parameters were evaluated by reference search and the calculation of a na & iuml;ve pooled method. After oral administration, the concentration-time profile was best described by a one-compartment open model. The absorption rate constant (Ka), apparent distribution volume (V), and systemic clearance (CL) were estimated to be 3.11/h, 4.36 L/kg, and 0.079 L/h/kg, respectively. After intravenous administration, the concentration-time curve was best simulated by a two-compartment open model. The apparent distribution volume of the central compartment (V1), apparent distribution volume of the peripheral compartment (V2), CL, and clearance from the central compartment to the peripheral compartment (CL2) were estimated to be 0.42, 2.05 L/kg, 0.067, and 2.94 L/h/kg, respectively. Finally, the bioavailability was calculated to be 84.81%. The parameter of AUC/minimum inhibitory concentration value was estimated to be more than 506.32 for Aeromonas hydrophila, Aeromonas sobria, and Flavobacterium columnare indicating that EF at 20 mg/kg has high effectiveness for these pathogens. This study supported a concise method for conducting PK study in aquatic animals that facilitated the development of PK methodology in aquaculture.
引用
收藏
页码:201 / 211
页数:11
相关论文
共 36 条
[1]  
CFFA, 2024, CHINA FISHERY STAT Y
[2]   Pharmacokinetics of enrofloxacin in snakehead fish, Channa argus [J].
Fang, X. ;
Zhou, J. ;
Liu, X. .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2016, 39 (02) :209-212
[3]   Pharmacokinetics of enrofloxacin in allogynogenetic silver crucian carp, Carassius auratus gibelio [J].
Fang, X. ;
Liu, X. ;
Liu, W. ;
Lu, C. .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2012, 35 (04) :397-401
[4]  
Food and Agricultural Organization, 2021, COMMISSION IMPLEMENT
[5]   Provisional epidemiological cutoff values for standard broth microdilution susceptibility testing of Flavobacterium columnare [J].
Gieseker, C. M. ;
Crosby, T. C. ;
Woods, L. C., III .
JOURNAL OF FISH DISEASES, 2017, 40 (05) :679-686
[6]  
Greenwell Martin G, 2003, Vet Clin North Am Exot Anim Pract, V6, P169, DOI 10.1016/S1094-9194(02)00021-X
[7]   Pharmacokinetic disposition of enrofloxacin in brown trout (Salmo trutta fario) after oral and intravenous administrations [J].
Koc, F. ;
Uney, K. ;
Atamanalp, M. ;
Tumer, I. ;
Kaban, G. .
AQUACULTURE, 2009, 295 (1-2) :142-144
[8]   Naive averaged, nave pooled, and population pharmacokinetics of orally administered marbofloxacin in juvenile harbor seals [J].
KuKanich, Butch ;
Huff, David ;
Riviere, Jim E. ;
Papich, Mark G. .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2007, 230 (03) :390-395
[9]   Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine [J].
Mckellar, OA ;
Bruni, SFS ;
Jones, DG .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2004, 27 (06) :503-514
[10]  
Papich M. G., 2016, SAUNDERS HDB VET DRU, V4th, P287, DOI DOI 10.1016/B978-0-323-24485-5.00240-0